Aquestive Therapeutics OverviewAquestive Therapeutics Net Income
Profitability analysis for AQST.
Quarterly Net Income
-$8.06M
↑ 64.86% YoY
As of Mar 2026
Annual Net Income (TTM)
-$68.91M
↓ 27.05% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...